DoseVue NV is a privately held medical device company developing in-vivo dosimetry solutions for radiation therapy. The company was founded as the first spin-off of the Belgian Nuclear Research Center (SCK•CEN), an internationally renowned player in the field of radiation protection and dosimetry research. DoseVue’s first CE-marked product, the DoseWire™ Series 200, is a real-time in-vivo dosimetry device improving safety in a range of applications, enhancing the clinical efficacy of radiation therapy to ensure better patient outcomes.